Alzheimer’s: scientists from Cuba and Mexico advance research for treatment

Havana, March 30 (EFE). Scientists of Cuba and Mexico develop a molecule that could help joint research for the treatment and therapy of Alzheimer’sthe official newspaper Granma reported this Saturday.

The preliminary result of one of these scientific projects showed the “powerful neuroprotective capacity” of the Cneuro-201 molecule at the time of “disaggregate amyloid plaques and inhibit the aggregation of amyloid peptides” (proteins that accumulate in the brain).

The general director of the Cuban Neuroscience Center (Cneuro), Mitchell Valdés, declared to the newspaper Granma that they verified that “This product can cross the blood-brain barrier and bind to amyloid plaques, which characterize Alzheimer’s disease”.

“With the results obtained we will be able to form a mathematical model that allows us to design an effective and safe dosing scheme in humans”added the expert.

The Center for Research and Advanced Studies of the National Polytechnic Institute, the National Autonomous University of Mexico (Unam) and the Institute of Neurobiology participate in the study on the Mexican side, with the support of the National Council of Humanities, Science and Technology of Mexico.

“With the participation of the UNAM Faculty of Medicine and its positron emission tomography unit, we also work together on the ccreation of a method for early diagnosis of Alzheimer’s, through the use of the Cuban radiopharmaceutical Cneuro-120″indicated Valdés.

The German neurologist Alois Alzheimer described the disease that bears his name in 1906. It currently affects millions of people in the world.

According to the newspaper Granma, 160,000 people in Cuba suffer from this type of dementia that, progressively, destroys the patient’s memory and leaves him helpless.